These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19662546)

  • 1. Activity of Ertapenem and Ceftriaxone in the eradication of Salmonella in a model of experimental peritonitis in mice.
    Lozano FS; García MI; García E; González B; García MB; García FJ; García JE
    Rev Esp Quimioter; 2009 Sep; 22(3):135-8. PubMed ID: 19662546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extraintestinal focal infections in adults with Salmonella enterica serotype Choleraesuis bacteremia.
    Chen PL; Wu CJ; Chang CM; Lee HC; Lee NY; Shih HI; Lee CC; Ko NY; Wang LR; Ko WC
    J Microbiol Immunol Infect; 2007 Jun; 40(3):240-7. PubMed ID: 17639165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence of ceftriaxone resistance in ciprofloxacin-resistant Salmonella enterica serotype Choleraesuis isolates causing recurrent infection.
    Sun HY; Tseng SP; Hsueh PR; Hung CC; Hsieh SM; Teng LJ; Ho SW
    Clin Infect Dis; 2005 Jan; 40(1):208-9. PubMed ID: 15614720
    [No Abstract]   [Full Text] [Related]  

  • 4. A study evaluating the efficacy, safety, and tolerability of ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults.
    Ortiz-Ruiz G; Caballero-Lopez J; Friedland IR; Woods GL; Carides A;
    Clin Infect Dis; 2002 Apr; 34(8):1076-83. PubMed ID: 11914996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy.
    Wells WG; Woods GL; Jiang Q; Gesser RM
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii67-74. PubMed ID: 15150185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Salmonella enterica isolates from infants and toddlers in Wuhan, China.
    Cui S; Li J; Sun Z; Hu C; Jin S; Li F; Guo Y; Ran L; Ma Y
    J Antimicrob Chemother; 2009 Jan; 63(1):87-94. PubMed ID: 18984647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular epidemiology and antimicrobial susceptibility of Salmonella enterica serotype Stanley isolates in Taiwan.
    Huang KY; Hong YW; Wang MH; Chu C; Su LH; Chiou CS; Chiu CH
    J Microbiol Immunol Infect; 2007 Oct; 40(5):411-8. PubMed ID: 17932601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Carbapenems against clinical, nontyphoid Salmonella isolates: results from in vitro and in vivo animal studies.
    Tang HJ; Chen CC; Zhang CC; Cheng KC; Chiang SR; Chiu YH; Ku YH; Ko WC; Chuang YC
    Antimicrob Agents Chemother; 2012 Jun; 56(6):2916-22. PubMed ID: 22470122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and tolerability of ertapenem versus ceftriaxone in a double-blind study performed in children with complicated urinary tract infection, community-acquired pneumonia or skin and soft-tissue infection.
    Arguedas A; Cespedes J; Botet FA; Blumer J; Yogev R; Gesser R; Wang J; West J; Snyder T; Wimmer W;
    Int J Antimicrob Agents; 2009 Feb; 33(2):163-7. PubMed ID: 18945594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults: combined analysis of two multicentre randomized, double-blind studies.
    Ortiz-Ruiz G; Vetter N; Isaacs R; Carides A; Woods GL; Friedland I
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii59-66. PubMed ID: 15150184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Travel-acquired salmonellosis due to Salmonella Kentucky resistant to ciprofloxacin, ceftriaxone and co-trimoxazole and associated with treatment failure.
    Collard JM; Place S; Denis O; Rodriguez-Villalobos H; Vrints M; Weill FX; Baucheron S; Cloeckaert A; Struelens M; Bertrand S
    J Antimicrob Chemother; 2007 Jul; 60(1):190-2. PubMed ID: 17449886
    [No Abstract]   [Full Text] [Related]  

  • 12. A new therapeutic challenge for old pathogens: community-acquired invasive infections caused by ceftriaxone- and ciprofloxacin-resistant Salmonella enterica serotype choleraesuis.
    Ko WC; Yan JJ; Yu WL; Lee HC; Lee NY; Wang LR; Chuang YC
    Clin Infect Dis; 2005 Jan; 40(2):315-8. PubMed ID: 15655754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serovar distribution and antibiotic susceptibility of nontyphoidal Salmonella isolated from pediatric patients in Jakarta, Indonesia.
    Bukitwetan P; Suryawidjaja JE; Salim OCh; Hidayat A; Herwana E; Lesmana M
    Southeast Asian J Trop Med Public Health; 2007 Nov; 38(6):1088-94. PubMed ID: 18613551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of carbapenem resistance during therapy for non-typhoid Salmonella infection.
    Su LH; Wu TL; Chiu CH
    Clin Microbiol Infect; 2012 Apr; 18(4):E91-4. PubMed ID: 22329543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of Salmonella enterica serotype Isangi from a suspected case of enteric encephalopathy.
    Kulkarni RD; Ajantha GS; Shubhada C; Jain P
    Indian J Med Microbiol; 2009; 27(1):65-6. PubMed ID: 19172065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term ceftriaxone therapy for treatment of severe non-typhoidal Salmonella enterocolitis.
    Lin TY; Chiu CH; Lin PY; Wang MH; Su LH; Lin TY
    Acta Paediatr; 2003 May; 92(5):537-40. PubMed ID: 12839280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ertapenem versus ceftriaxone for the treatment of complicated infections: a meta-analysis of randomized controlled trials.
    Bai N; Sun C; Wang J; Cai Y; Liang B; Zhang L; Liu Y; Wang R
    Chin Med J (Engl); 2014; 127(6):1118-25. PubMed ID: 24622445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a 5 day enrofloxacin treatment on Salmonella enterica serotype Typhimurium DT104 in the pig.
    Delsol AA; Woodward MJ; Roe JM
    J Antimicrob Chemother; 2004 Feb; 53(2):396-8. PubMed ID: 14711838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of multidrug-resistant human isolates of MDR-ACSSuT Salmonella Typhimurium and MDR-AmpC Salmonella Newport in the United States, 2003-2005.
    Greene SK; Stuart AM; Medalla FM; Whichard JM; Hoekstra RM; Chiller TM
    Foodborne Pathog Dis; 2008 Oct; 5(5):669-80. PubMed ID: 18851677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Salmonella spp. with resistance to extended-spectrum cephalosporins and fluoroquinolones isolated in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2004).
    Biedenbach DJ; Toleman M; Walsh TR; Jones RN
    Diagn Microbiol Infect Dis; 2006 Jan; 54(1):13-21. PubMed ID: 16290025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.